Metabolic syndrome and prevention of migraine headache

Brain and Nerve

Volumn 61, Issue 10, 2009, Pages 1143-1153

  Takeshima, Takao ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Adiponectin; Cytokine; Metabolic syndrome (MetS); Obesity; Orexin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; OREXIN;

ALLELE; ARTICLE; CALCITONIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; EXERCISE; FOOD INTAKE; GENETIC RISK; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; MIGRAINE; MORBIDITY; OBESITY; SLEEP;

ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIET; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIGRAINE DISORDERS; OBESITY;

EID: 70350290414     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41: 629-637, 2001
2. Kruit MC, Van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, et al: Migraine as a risk factor for subclinical brain lesions. JAMA 291: 427-434, 2004 (Pubitemid 38129746)
3. Bigal ME, Lipton RB: Concepts and mechanisms of migraine chronification. Headache 48: 7-15, 2008
4. Marmura MJ: Systemic abnormalities in migraine: what comes first? Neurologist 15: 53-54, 2009
5. Lipton RB, Silberstein SD: Why study the comorbidity of migraine. Neurology 44 Suppl 7: S4-S5, 1994
6. Tietjen GE, Herial NA, Hardgrove J, Utley C, White L: Migraine comorbidity constellations. Headache 47: 857-865, 2007
7. Guldiken B, Guldiken S, Taskiran B, Koc G, Turgut N, et al: Migraine in metabolic syndrome. Neurologist 15: 55-58, 2009
8. Horev A, Wirguin I, Lantsberg L, Ifergane G: A high incidence of migraine with aura among morbidly obese women. Headache 45: 936-938, 2005 (Pubitemid 41045373)
9. MacGregor EA: Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3: 354-361, 2004 (Pubitemid 38648856)
10. Bigal ME, Lieberman JN, Lipton RB: Obesity and migraine: a population study. Neurology 66: 545-550, 2006
11. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, et al: Migraine and risk of cardiovascular disease in women. JAMA 296: 283-291, 2006 (Pubitemid 44079312)
12. Ford ES, Li C, Pearson WS, Zhao G, Strine TW, et al: Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 28: 1270-1276, 2008
13. Mattsson P: Migraine headache and obesity in women aged 40-74 years: a population-based study. Cephalalgia 27: 877-880, 2007
14. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, et al: Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64: 614-620, 2005 (Pubitemid 40261888)
15. Bigal ME, Lipton RB: Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67: 252-257, 2006
16. Split W, Szydlowska M: Headaches in non insulin-dependent diabetes mellitus. Funct Neurol 12: 327-332, 1997 (Pubitemid 28156650)
17. Jousilahti P, Tuomilehto J, Rastenyte D, Vartiainen E: Headache and the risk of stroke: a prospective observational cohort study among 35,056 Finnish men and women. Arch Intern Med 163: 1058-1062, 2003 (Pubitemid 36548932)
18. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, et al: Association between migraine and asthma: matched case-control study. Br J Gen Pract 52: 723-727, 2002 (Pubitemid 36187594)
19. Cook NR, Bensenor IM, Lotufo PA, Lee IM, Skerrett PJ, et al: Migraine and coronary heart disease in women and men. Headache 42: 715-727, 2002 (Pubitemid 35291505)
20. Burn WK, Machin D, Waters WE: Prevalence of migraine in patients with diabetes. Br Med J (Clin Res Ed) 289: 1579-1580, 1984
21. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA: Headache prevalence related to diabetes mellitus. The Head-HUNT study. Eur J Neurol 14: 738-744, 2007 (Pubitemid 47012168)
22. Saunders K, Merikangas K, Low NC, Von KM, Kessler RC: Impact of comorbidity on headache-related disability. Neurology 70: 538-547, 2008 (Pubitemid 351653379)
23. Rainero I, Limone P, Ferrero M, Valfre W, Pelissetto C, et al: Insulin sensitivity is impaired in patients with migraine. Cephalalgia 25: 593-597, 2005 (Pubitemid 41026024)
24. Sacco S, Cerone D, Carolei A: Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 9: 237-248, 2008
25. Cirillo M, Stellato D, Lombardi C, De Santo NG, Covelli V: Headache and cardiovascular risk factors: positive association with hypertension. Headache 39: 409-416, 1999 (Pubitemid 29359547)
26. Franceschi M, Colombo B, Rossi P, Canal N: Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA). Headache 37: 7982, 1997
27. Markush RE, Karp HR, Heyman A, O'Fallon WM: Epidemiologic study of migraine symptoms in young women. Neurology 25: 430-435, 1975
28. Chen TC, Leviton A, Edelstein S, Ellenberg JH: Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 44: 1024-1028, 1987
29. Tzourio C, Gagniere B, El Amrani M, Alperovitch A, Bousser MG: Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 23: 914-920, 2003
30. Gudmundsson LS, Thorgeirsson G, Sigfusson N, Sigvaldason H, Johannsson M: Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21 537 subjects. The Reykjavik Study. Cephalalgia 26: 436-444, 2006
31. Tronvik E, Stovner LJ, Hagen K, Holmen J, Zwart JA: High pulse pressure protects against headache: prospective and cross-sectional data (HUNT study). Neurology 70: 1329-1336, 2008 (Pubitemid 351550337)
32. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB: Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72: 1864-1871, 2009
33. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, et al: The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 96: 762-764, 2000
34. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, et al: Migraine and MTHFR C677T genotype in a population-based sample. Annals of Neurology 59: 372-375, 2006 (Pubitemid 43202492)
35. Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, et al: Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 374: 129-131, 2005 (Pubitemid 40092210)
36. No To Shinkei 56: 645-654, 2004
37. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K: Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128: 209-214, 2007 (Pubitemid 46367415)
38. Bigal ME, Lipton RB, Holland PR, Goadsby PJ: Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 68: 1851-1861, 2007
39. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, et al: Plasma cytokine levels in migraineurs and controls. Headache 45: 926-931, 2005 (Pubitemid 41045371)
40. Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH: Calcitonin gene-related peptide in human obesity. Peptides 12: 861-863, 1991
41. Peterlin BL, Bigal ME, Tepper SJ, Urakaze M, Sheftell FD, et al: Migraine and adiponectin: is there a connection? Cephalalgia 27: 435-446, 2007
42. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, et al: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62: 788-790, 2004 (Pubitemid 38298959)
43. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB: Chronic daily headache: identification of factors associated with induction and transformation. Headache 42: 575-581, 2002
44. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA: Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59: 652-661, 2006
45. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G: Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289: 65-69, 2003 (Pubitemid 36026279)
46. Medeiros FL, Medeiros PL, Valenca MM, Dodick D: Simvastatin for migraine prevention. Headache 47: 855-856, 2007
47. Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, et al: Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44: 8-19, 2004 (Pubitemid 38116657)